Quantcast
Last updated on April 20, 2014 at 14:04 EDT

Latest Overdiagnosis Stories

2014-04-02 11:14:07

In a personal view published today, a general practitioner says that the new targets for diagnosing dementia will lead to more harm than good The government is putting pressure on commissioners, and in turn general practitioners, to make more diagnoses of dementia, but no analysis has been done to assess the harm that these targets could cause. Dr Martin Brunet, a GP from Surrey, says that "medicine depends on a fundamental, unspoken agreement between patients and doctors […] the only...

2014-04-02 10:46:54

Complex benefits and harms of mammography require individualized approach A comprehensive review of 50 year's worth of international studies assessing the benefits and harms of mammography screening suggests that the benefits of the screening are often overestimated, while harms are underestimated. And, since the relative benefits and harms of screening are related to a complex array of clinical factors and personal preferences, physicians and patients need more guidance on how best to...

2014-03-11 23:04:21

Nation's leading independent radiology practice network not alone in expressing frustration over misleading findings. (PRWEB) March 11, 2014 In response to the recent media coverage surrounding an article published in the British Medical Journal (BMJ) questioning the value of screening mammography by revisiting data from the Canadian Breast Cancer Screening Study (CNBSS), Strategic Radiology (SR) fully aligns itself with organizations such as American Congress of Obstetricians and...

2014-01-10 08:23:58

Nomogram aims to enable informed decision-making and personalized treatment SEATTLE, Jan. 10, 2014 /PRNewswire/ -- Studies have found that prostate cancer is overdiagnosed in up to 42 percent of cases, prompting men to receive unnecessary treatment that can cause devastating side effects, including impotence and incontinence. Now, researchers at Fred Hutchinson Cancer Research Center and the University of Washington have developed a personalized tool that can predict the likelihood...

2014-01-07 10:42:10

Using a nomogram that incorporates age, Gleason score, and prostate-specific antigen (PSA) level at diagnosis, individual risks that a screen-detected prostate cancer has been overdiagnosed can be estimated, according to a new study published January 6 in the Journal of the National Cancer Institute. The authors used a standard definition of overdiagnosis to refer to a cancer that would not have become symptomatic or clinically identifiable if it had not been detected by screening....

2013-12-10 10:21:24

Data from the National Lung Cancer Screening Trial (NLST)—conducted by the American College of Radiology Imaging Network and National Cancer Institute Lung Screening Study—provided researchers the opportunity to investigate the probability that a cancer detected with screening low-dose computed tomography (LDCT) would not have progressed to become life threatening. The results of this investigation published online today in JAMA Internal Medicine suggest that up to 18 percent of the...

2013-12-09 23:02:27

18 percent of lung cancers detected by low-dose CT are indolent according to ECOG-ACRIN Cancer Research Group study. Philadelphia, PA (PRWEB) December 09, 2013 An analysis of data from the National Lung Screening Trial (NLST), the results of which were published today in JAMA Internal Medicine, suggests that more than 18 percent of lung cancers detected by low-dose computed tomography (LDCT or low-dose CT) may be indolent. “This is another important piece of information that helps us...

2013-10-28 08:28:40

--Pilot Study Results Demonstrate the Feasibility of Using Sputum Samples and the Cell-CT Platform to Non-Invasively Detect the Presence or Absence of Lung Cancer-- SYDNEY and PHOENIX, Oct. 28, 2013 /PRNewswire/ -- VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today reported clinical data showing that its automated 3D cell imaging platform, the Cell-CT(TM), can detect lung cancer in sputum samples with high...

2013-10-22 10:27:09

A survey finds that most patients are not being told about the possibility of overdiagnosis and overtreatment as a result of cancer screenings, according to report in a research letter by Odette Wegwarth, Ph.D., and Gerd Gigerenzer, Ph.D., of the Max Planck Institute for Human Development, Berlin, Germany. Cancer screenings can find treatable disease at an earlier stage but they can also detect cancers that will never progress to cause symptoms. Detection of these early, slow-growing...

2013-09-12 23:02:30

Prominent physician, Dr. Bert Vorstman, warns about overreacting during prostate cancer awareness month. Miami, FL (PRWEB) September 12, 2013 Prominent Florida prostate cancer specialist, Bert Vorstman MD, MS, FAAP, FRACS, FACS, has posted his latest blog, “Made Sick from Prostate Cancer Awareness and Screening” on his URO HEALTH blog site.Dr Bert Vorstman is a Coral Springs based urological surgeon and patient advocate with some 30 years of surgical experience. Dr. Vorstman...